{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:22:33Z","timestamp":1770283353980,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,21]]},"DOI":"10.7759\/cureus.52664","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T16:04:01Z","timestamp":1705853041000},"source":"Crossref","is-referenced-by-count":2,"title":["A Systematic Review and Meta-Analysis of the Safety and Efficacy of 0.25% Lotilaner Ophthalmic Solution in the Treatment of Demodex Blepharitis"],"prefix":"10.7759","author":[{"given":"Bakhtawar","family":"Awan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Elsaigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areej","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Badee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Loomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahya","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Abdelmaksoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"American Academy of Opthalmology. (2022). Accessed. 2023: https:\/\/www.aao.org\/eye-health\/tips-prevention\/demodex-mites-blepharitis-itchy-red-eyelid-eyelash.."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTO.S142708","article-title":"Demodex blepharitis: clinical perspectives","volume":"10","author":"Fromstein SR","year":"2018","unstructured":"Fromstein SR, Harthan JS, Patel J, Opitz DL. Demodex blepharitis: clinical perspectives. Clin Optom (Auckl). 2018, 10:57-63. 10.2147\/OPTO.S142708","journal-title":"Clin Optom (Auckl)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013333.pub2","article-title":"Tea tree oil for Demodex blepharitis","volume":"6","author":"Savla K","year":"2020","unstructured":"Savla K, Le JT, Pucker AD. Tea tree oil for Demodex blepharitis. Cochrane Database Syst Rev. 2020, 6:CD013333. 10.1002\/14651858.CD013333.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000250228","article-title":"The hair follicle mites Demodex folliculorum and Demodex brevis: biology and medical importance. A review","volume":"162","author":"Rufli T","year":"1981","unstructured":"Rufli T, Mumcuoglu Y. The hair follicle mites Demodex folliculorum and Demodex brevis: biology and medical importance. A review. Dermatologica. 1981, 162:1-11. 10.1159\/000250228","journal-title":"Dermatologica"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.123498","article-title":"Human demodex mite: the versatile mite of dermatological importance","volume":"59","author":"Rather PA","year":"2014","unstructured":"Rather PA, Hassan I. Human demodex mite: the versatile mite of dermatological importance. Indian J Dermatol. 2014, 59:60-6. 10.4103\/0019-5154.123498","journal-title":"Indian J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8949683","article-title":"The prevalence of Demodex folliculorum and Demodex brevis in cylindrical dandruff patients","volume":"2019","author":"Zhong J","year":"2019","unstructured":"Zhong J, Tan Y, Li S, Peng L, Wang B, Deng Y, Yuan J. The prevalence of Demodex folliculorum and Demodex brevis in cylindrical dandruff patients. J Ophthalmol. 2019, 2019:8949683. 10.1155\/2019\/8949683","journal-title":"J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1645\/18-46","article-title":"Evaluation of the efficacy of tea tree oil on the density of Demodex mites (Acari: Demodicidae) and ocular symptoms in patients with Demodectic blepharitis","volume":"104","author":"Karakurt Y","year":"2018","unstructured":"Karakurt Y, Zeytun E. Evaluation of the efficacy of tea tree oil on the density of Demodex mites (Acari: Demodicidae) and ocular symptoms in patients with Demodectic blepharitis. J Parasitol. 2018, 104:473-8. 10.1645\/18-46","journal-title":"J Parasitol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001361","article-title":"Ocular demodicosis as a potential cause of ocular surface inflammation","volume":"36","author":"Luo X","year":"2017","unstructured":"Luo X, Li J, Chen C, Tseng S, Liang L. Ocular demodicosis as a potential cause of ocular surface inflammation. Cornea. 2017, 36:S9-14. 10.1097\/ICO.0000000000001361","journal-title":"Cornea"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097%2FACI.0b013e32833df9f4","article-title":"Pathogenic role of Demodex mites in blepharitis","volume":"10","author":"Liu J","year":"2010","unstructured":"Liu J,  Hosam S, Scheffer T. Pathogenic role of Demodex mites in blepharitis. Curr Opin Allergy Clin Immunol. 2010, 10:505. 10.1097%2FACI.0b013e32833df9f4","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.196","article-title":"Retrospective analysis of the association between Demodex infestation and rosacea","volume":"146","author":"Zhao YE","year":"2010","unstructured":"Zhao YE, Wu LP, Peng Y, Cheng H. Retrospective analysis of the association between Demodex infestation and rosacea. Arch Dermatol. 2010, 146:896-902. 10.1001\/archdermatol.2010.196","journal-title":"Arch Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/opo.12691","article-title":"Ocular Demodex: a systematic review of the clinical literature","volume":"40","author":"Zhang AC","year":"2020","unstructured":"Zhang AC, Muntz A, Wang MT, Craig JP, Downie LE. Ocular Demodex: a systematic review of the clinical literature. Ophthalmic Physiol Opt. 2020, 40:389-432. 10.1111\/opo.12691","journal-title":"Ophthalmic Physiol Opt"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2020.04.011","article-title":"Topical ivermectin-metronidazole gel therapy in the treatment of blepharitis caused by Demodex spp.: a randomized clinical trial","volume":"44","author":"\u00c1vila MY","year":"2021","unstructured":"\u00c1vila MY, Mart\u00ednez-Pulgar\u00edn DF, Rizo Madrid C. Topical ivermectin-metronidazole gel therapy in the treatment of blepharitis caused by Demodex spp.: a randomized clinical trial. Cont Lens Anterior Eye. 2021, 44:101326. 10.1016\/j.clae.2020.04.011","journal-title":"Cont Lens Anterior Eye"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.60663","article-title":"The impact of age, sex, blepharitis, rosacea and rheumatoid arthritis on Demodex mite infection","volume":"14","author":"S\u0119dzikowska A","year":"2018","unstructured":"S\u0119dzikowska A, Os\u0119ka M, Skopi\u0144ski P. The impact of age, sex, blepharitis, rosacea and rheumatoid arthritis on Demodex mite infection. Arch Med Sci. 2018, 14:353-6. 10.5114\/aoms.2016.60663","journal-title":"Arch Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002911","article-title":"Update on the management of Demodex blepharitis","volume":"41","author":"Shah PP","year":"2022","unstructured":"Shah PP, Stein RL, Perry HD. Update on the management of Demodex blepharitis. Cornea. 2022, 41:934-9. 10.1097\/ICO.0000000000002911","journal-title":"Cornea"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000526296","article-title":"Comparison of different anti-Demodex strategies: a systematic review and meta-analysis","volume":"239","author":"Li J","year":"2023","unstructured":"Li J, Wei E, Reisinger A, French LE, Clanner-Engelshofen BM, Reinholz M. Comparison of different anti-Demodex strategies: a systematic review and meta-analysis. Dermatology. 2023, 239:12-31. 10.1159\/000526296","journal-title":"Dermatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2021.1875006","article-title":"In vivo confocal microscopy in blepharitis patients with ocular Demodex infestation","volume":"30","author":"Yildiz-Tas A","year":"2022","unstructured":"Yildiz-Tas A, Arici C, Mergen B, Sahin A. In vivo confocal microscopy in blepharitis patients with ocular Demodex infestation. Ocul Immunol Inflamm. 2022, 30:1378-83. 10.1080\/09273948.2021.1875006","journal-title":"Ocul Immunol Inflamm"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2010.11.024","article-title":"Clinical treatment of ocular Demodex folliculorum by systemic ivermectin","volume":"151","author":"Holzchuh FG","year":"2011","unstructured":"Holzchuh FG, Hida RY, Moscovici BK, Villa Albers MB, Santo RM, Kara-Jos\u00e9 N, Holzchuh R. Clinical treatment of ocular Demodex folliculorum by systemic ivermectin. Am J Ophthalmol. 2011, 151:1030-1034.e1. 10.1016\/j.ajo.2010.11.024","journal-title":"Am J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S198585","article-title":"Improvement in ocular symptoms and signs in patients with Demodex anterior blepharitis using a novel terpinen-4-ol (2.5%) and hyaluronic acid (0.2%) cleansing wipe","volume":"13","author":"Messaoud R","year":"2019","unstructured":"Messaoud R, El Fekih L, Mahmoud A, Ben Amor H, Bannour R, Doan S, Khairallah M. Improvement in ocular symptoms and signs in patients with Demodex anterior blepharitis using a novel terpinen-4-ol (2.5%) and hyaluronic acid (0.2%) cleansing wipe. Clin Ophthalmol. 2019, 13:1043-54. 10.2147\/OPTH.S198585","journal-title":"Clin Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.201194","article-title":"The efficacy of oral ivermectin for the treatment of chronic blepharitis in patients tested positive for Demodex spp","volume":"95","author":"Filho PA","year":"2011","unstructured":"Filho PA, Hazarbassanov RM, Grisolia AB, Pazos HB, Kaiserman I, Gomes J\u00c1. The efficacy of oral ivermectin for the treatment of chronic blepharitis in patients tested positive for Demodex spp. Br J Ophthalmol. 2011, 95:893-5. 10.1136\/bjo.2010.201194","journal-title":"Br J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097%2FICO.0000000000002506","article-title":"Effects of terpinen-4-ol on meibomian gland epithelial cells in vitro","volume":"39","author":"Chen D","year":"2020","unstructured":"Chen D, Wang J, Sullivan D. Effects of terpinen-4-ol on meibomian gland epithelial cells in vitro. Cornea. 2020, 39:1541. 10.1097%2FICO.0000000000002506","journal-title":"Cornea"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01965-7","article-title":"Correction to: Lotilaner ophthalmic solution 0.25%: first approval","volume":"83","author":"Syed YY","year":"2023","unstructured":"Syed YY. Correction to: Lotilaner ophthalmic solution 0.25%: first approval. Drugs. 2023, 83:1543. 10.1007\/s40265-023-01965-7","journal-title":"Drugs"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-018-2970-x","article-title":"Lotilaner - a novel formulation for cats provides systemic tick and flea control","volume":"11","author":"Wright I","year":"2018","unstructured":"Wright I. Lotilaner - a novel formulation for cats provides systemic tick and flea control. Parasit Vectors. 2018, 11:407. 10.1186\/s13071-018-2970-x","journal-title":"Parasit Vectors"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston M","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019, 10:ED000142. 10.1002\/14651858.ED000142","journal-title":"Cochrane Database Syst Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al.. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"ref26","unstructured":"Opthalmology. Clinically Meaningful Improvements. (2023). https:\/\/www.aaojournal.org\/."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.05.030","article-title":"Lotilaner ophthalmic solution 0.25% for Demodex blepharitis: randomized, vehicle-controlled, multicenter, phase 3 trial (Saturn-2)","volume":"130","author":"Gaddie IB","year":"2023","unstructured":"Gaddie IB, Donnenfeld ED, Karpecki P, et al.. Lotilaner ophthalmic solution 0.25% for Demodex blepharitis: randomized, vehicle-controlled, multicenter, phase 3 trial (Saturn-2). Ophthalmology. 2023, 130:1015-23. 10.1016\/j.ophtha.2023.05.030","journal-title":"Ophthalmology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2021.101492","article-title":"Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: a randomized, controlled, double-masked clinical trial","volume":"45","author":"Gonzalez-Salinas R","year":"2022","unstructured":"Gonzalez-Salinas R, Karpecki P, Yeu E, et al.. Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: a randomized, controlled, double-masked clinical trial. Cont Lens Anterior Eye. 2022, 45:101492. 10.1016\/j.clae.2021.101492","journal-title":"Cont Lens Anterior Eye"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2022.2093755","article-title":"Treatment of Demodex blepharitis: a prospective, randomized, controlled, double-masked clinical trial comparing topical lotilaner ophthalmic solution, 0.25% eyedrops to vehicle","volume":"31","author":"Yeu E","year":"2022","unstructured":"Yeu E, Holdbrook M, Baba SN, et al.. Treatment of Demodex blepharitis: a prospective, randomized, controlled, double-masked clinical trial comparing topical lotilaner ophthalmic solution, 0.25% eyedrops to vehicle. Ocul Immunol Inflamm. 2022, 31:1653-61. 10.1080\/09273948.2022.2093755","journal-title":"Ocul Immunol Inflamm"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003097","article-title":"Lotilaner ophthalmic solution, 0.25%, for the treatment of Demodex blepharitis: results of a prospective, randomized, vehicle-controlled, double-masked, pivotal trial (Saturn-1)","volume":"42","author":"Yeu E","year":"2023","unstructured":"Yeu E, Wirta DL, Karpecki P, Baba SN, Holdbrook M. Lotilaner ophthalmic solution, 0.25%, for the treatment of Demodex blepharitis: results of a prospective, randomized, vehicle-controlled, double-masked, pivotal trial (Saturn-1). Cornea. 2023, 42:435-43. 10.1097\/ICO.0000000000003097","journal-title":"Cornea"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2019.09.001","article-title":"Palpebral and facial skin infestation by Demodex folliculorum","volume":"43","author":"Aumond S","year":"2020","unstructured":"Aumond S, Bitton E. Palpebral and facial skin infestation by Demodex folliculorum. Cont Lens Anterior Eye. 2020, 43:115-22. 10.1016\/j.clae.2019.09.001","journal-title":"Cont Lens Anterior Eye"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.oftale.2017.07.002","article-title":"High prevalence of Demodex spp. infestation among patients with posterior blepharitis: correlation with age and cylindrical dandruff","volume":"92","author":"Lopez-Ponce D.","year":"2017","unstructured":"Lopez-Ponce D., Zuazo F., Cartes C.\r\n. High prevalence of Demodex spp. infestation among patients with posterior blepharitis: correlation with age and cylindrical dandruff. Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition). 2017, 92:412-8. 10.1016\/j.oftale.2017.07.002","journal-title":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2012.27.12.1574","article-title":"Ocular surface discomfort and Demodex: effect of tea tree oil eyelid scrub in Demodex blepharitis","volume":"27","author":"Koo H","year":"2012","unstructured":"Koo H, Kim TH, Kim KW, Wee SW, Chun YS, Kim JC. Ocular surface discomfort and Demodex: effect of tea tree oil eyelid scrub in Demodex blepharitis. J Korean Med Sci. 2012, 27:1574-9. 10.3346\/jkms.2012.27.12.1574","journal-title":"J Korean Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/217166-a-systematic-review-and-meta-analysis-of-the-safety-and-efficacy-of-025-lotilaner-ophthalmic-solution-in-the-treatment-of-demodex-blepharitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:02Z","timestamp":1707509642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/217166-a-systematic-review-and-meta-analysis-of-the-safety-and-efficacy-of-025-lotilaner-ophthalmic-solution-in-the-treatment-of-demodex-blepharitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,21]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.52664","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,21]]}}}